Neonatal seizures disrupt normal synaptic maturation and often lead to later-life epilepsy and cognitive deficits. During early life, the brain exhibits heightened synaptic plasticity, in part due to a developmental overabundance of Ca V 1.2 L-type voltage gated calcium (Ca 2+ ) channels (LT-VGCCs) and Ca
-permeable AMPARs (CP-AMPARs) lacking GluA2 subunits. We hypothesized that early-life seizures overactivate these channels, in turn dysregulating Ca 2+ -dependent signaling pathways including that of methyl CPG binding protein 2 (MeCP2), a transcription factor implicated in the autism spectrum disorder (ASD) Rett Syndrome. Here, we show that in vivo hypoxia-induced seizures (HS) in postnatal day (P)10 rats acutely induced phosphorylation of the neuronal-specific target of activity-dependent MeCP2 phosphorylation, S421, as well as its upstream activator CaMKII T286. We next identified mechanisms by which activity-dependent Ca 2+ influx induced MeCP2 phosphorylation using in vitro cortical and hippocampal neuronal cultures at embryonic day (E)18 + 10 days in vitro (DIV). In contrast to the prevalent role of NMDARs in the adult brain, we found that both CP-AMPARs and LTVGCCs mediated MeCP2 S421 and CaMKII T286 phosphorylation induced by kainic acid (KA) or high potassium chloride (KCl) stimulation. Furthermore, in vivo post-seizure treatment with the broad-spectrum AMPAR antagonist NBQX, the CP-AMPAR blocker IEM-1460, or the LT-VGCC antagonist nimodipine blocked seizure-induced MeCP2 phosphorylation. Collectively, these results demonstrate that early-life seizures dysregulate critical activity-dependent developmental signaling pathways, in part via CP-AMPAR and LT-VGCC activation, providing novel age-specific therapeutic targets for convergent pathways underlying epilepsy and ASDs.
Introduction
The neonatal brain exists in a heightened state of excitation, primed for activity-dependent synaptic plasticity, formation, and refinement (Rakhade and Jensen, 2009 ). This hyperexcitability, although ideal for learning and memory, renders the brain vulnerable to seizures (Ben Ari and Holmes, 2006; Jensen et al., 1992; Rakhade and Jensen, 2009; Wirrell et al., 2011) . Early-life seizures can alter development and plasticity of neuronal circuitry (Hernan et al., 2013; Isaeva et al., 2013; Swann, 2004; Zhou et al., 2011) , which may in turn lead to cognitive impairments and autistic-like behavior (Brooks-Kayal, 2010; LippmanBell et al., 2013; Lucas et al., 2011; Lugo et al., 2014) . Notably, many genetic autism spectrum disorders (ASDs) exhibit early-onset seizures (Berg et al., 2011; Tuchman, 2013) , indicating a convergence of cellular and molecular mechanisms in ASDs and seizures. Activity-dependent synaptogenesis and downstream signaling may be an important area for therapeutic target development in treating these disorders.
Hypoxic encephalopathy, the leading clinical cause of neonatal 
